Feasibility study of ADCs targeting TROP-2, HER2, and CD46 in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate.

Autor: Wang, Xingming1 (AUTHOR), Qi, Lin1 (AUTHOR), Chen, Minfeng1 (AUTHOR), Zhang, Ye2 (AUTHOR), Gao, Xiaomei3 (AUTHOR) lswindy_2012@163.com, Cai, Yi1 (AUTHOR) cai-yi@csu.edu.cn
Zdroj: World Journal of Urology. 7/11/2024, Vol. 42 Issue 1, p1-10. 10p.
Databáze: Academic Search Ultimate
Externí odkaz: